Vaccine for cervical cancer: SEC to review Serum Institute’s HPV jab trial data today

New Delhi [India] June 15: The first indigenously developed quadrivalent human papillomavirus (qHPV) vaccine against cervical cancer by the Serum Institute of India (SII) will be discussed by the Subject expert committee on Wednesday. The application for market authorization of the

Source: India News, India Breaking News, Latest news headlines in India – Oneindia News